Adagio Therapeutics Inc (ADGI)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Tillman U. Gerngross
Employees:
68
303 WYMAN STREET, SUITE 300, WALTHAM, MA 02451
(781) 530-3600

We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. We are developing our lead product candidate, ADG20, for the treatment and prevention of coronavirus disease 2019, or COVID-19, the disease caused by the virus SARS-CoV-2 and its variants.

Data as of 2021-10-17 10:56:16 -0400
Market Cap3.608 Billion Shares Outstanding111.252 Million Avg 30-day Volume574.335 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low59.5 / 20.5 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud

Are you looking for this stock instead?

View recent insider trading info

Funds Holding ADGI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADGI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCGUIRE TERRANCE

  • Director
8,531,700 2021-08-10 1

MITHRIL II LP

MITHRIL II GP LP

MITHRIL II UGP LLC

THIEL PETER

  • 10% Owner
11,241,580 2021-08-10 2

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
3,390,960 2021-08-10 1

ADIMAB, LLC

  • 10% Owner
27,845,995 2021-08-10 1

GERNGROSS TILLMAN U. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
27,845,995 2021-08-10 1

ROYAN AJAY

  • Director
  • 10% Owner
11,241,580 2021-08-10 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 22:15:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 21:45:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 21:15:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 20:45:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 20:15:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 19:45:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 19:15:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 18:45:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 18:15:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 17:45:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 17:15:03 UTC -0.8793 0.9493 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 16:45:03 UTC -0.9264 0.9964 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 16:15:04 UTC -0.9264 0.9964 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 15:45:03 UTC -0.9264 0.9964 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 15:15:03 UTC -0.9264 0.9964 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 14:45:03 UTC -0.9314 1.0014 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 14:15:03 UTC -0.9314 1.0014 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 13:45:03 UTC -0.9314 1.0014 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 13:15:03 UTC -0.9314 1.0014 100000
ADAGIO THERAPEUTICS INC ADGI 2021-10-22 12:45:03 UTC -0.9314 1.0014 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments